Skip to main content
. 2015 May 15;7(5):967–975.

Figure 1.

Figure 1

Different doxorubicin sensitivity in breast cancer cells. Three breast cancer cell lines including MCF-7, MDA-MB-231 and Bcap-37 were incubated with doxorubicin for 48 h. Cell viability was measured using CCK-8 method (A). Western blot was performed to determine GPR30 expression in MCF-7, MDA-MB-231 and Bcap-37 cells (B). *P < 0.05, compared with Bcap-37; #P < 0.05, compared with MCF-7.